| Ytd | 107.73% | |
| 1y | 65.54% |
| Open | 230.95 | Prev Close | 228.03 | Low | 230.58 | High | 235.91 | Mkt Cap | 15.14B |
| Vol | 30.13K | Avg Vol | 847.45K | EPS | 10.38 | P/E | 22.73 | Forward P/E | 12.96 |
| Beta | 0.91 | Short Ratio | 5.77 | Inst. Own | 52.65% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 191.16 | 200-d Avg | 145.61 | 1yr Est | 193.71 |
DVA News
DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 2, 2026.
DVA is advancing kidney care through IKC expansion, CMS CKCC progress and AI-driven dialysis schedul
DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 30, 2026.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
In the most recent trading session, DaVita HealthCare (DVA) closed at $217.04, indicating a +1.72% s
Analysts don't like to put "sell" ratings on S&P 500 stocks. So the fact they're willing to do it wi
LYB, HRB and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 26th, 2026.
The latest trading day saw DaVita HealthCare (DVA) settling at $213.04, representing a +1% change fr
DVA is expanding kidney care through outpatient, home-centered and value-based programs while invest
HRB, DVA and PBI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 24th, 2026.
DaVita and Fresenius Medical Care are taking different paths in kidney care, but which stock offers
Medical stocks like Centene, DaVita and BrightSpring could rally as SpaceX IPO-fueled market optimis
HRB, DVA and PBI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 22nd, 2026.
DaVita HealthCare (DVA) closed the most recent trading day at $207.91, moving 1.27% from the previou
Investors target stocks that have been on a bullish run. Stocks like MUSA, DVA, HPE and VSH are seei
DVA is expanding kidney care beyond hospitals with IKC, digital tools and AI to improve coordination
ECPG, DK and DVA made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 17, 2026.
DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 17, 2026.
DaVita operates more than 3,200 dialysis centers globally, serving roughly 295,000 patients with a d
DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 15, 2026.
TD Cowen analyst Ryan Langston maintains DaVita (NYSE:DVA) with a Hold and raises the price targe
Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and raises the
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price
U.S. stocks hit records as Trump's Iran memo sinks oil 6%, AMD soars 17% on data-center beat.
Top Wall Street analysts upgraded several top stocks. See all changes and ratings on Benzinga's
Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised
Deutsche Bank analyst Pito Chickering upgrades DaVita (NYSE:DVA) from Hold to Buy and raises the
DaVita (NYSE:DVA) reported quarterly earnings of $2.87 per share which beat the analyst consensus es
The latest 13F filing from Berkshire Hathaway reveals some of the final position changes made by War
Wall Street extended losses into midday trading Tuesday as geopolitical tensions in the Middle East
DaVita stock surged after the kidney care provider beat earnings estimates and issued strong 2026 gu
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price
DaVita (NYSE:DVA) reported quarterly earnings of $3.40 per share which beat the analyst consensus es
Warren Buffett's Berkshire Hathaway took a new stake in a member of the Magnificent Seven, while
TD Cowen analyst Ryan Langston maintains DaVita (NYSE:DVA) with a Hold and lowers the price targe
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and lowers the price
DaVita (NYSE:DVA) reported quarterly earnings of $2.51 per share which missed the analyst consensus
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and lowers the price
B of A Securities analyst Kevin Fischbeck maintains DaVita (NYSE:DVA) with a Underperform and low
DaVita reported a ransomware attack affecting 2.7 million patients, posted Q2 earnings above estimat
A look at the updated Berkshire Hathaway portfolio after the second quarter, including a new stake i
Warren Buffett has requested confidentiality in a new Berkshire Hathaway position. Will investors fi